MedTrace Logo

Exercise Intervention and Immunodeficiency

NCT07698197 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-07-23

No results posted yet for this study

Summary

The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.

Conditions

  • Primary Antibody Deficiency Disorders

Interventions

BEHAVIORAL

App-based exercise intervention

12 week structured moderate-intensity exercise intervention delivered via a mobile application

Sponsors & Collaborators

  • The Pump

    collaborator UNKNOWN

  • Yale University

    lead OTHER

Principal Investigators

  • Ryan Steele, DO, MSc · Yale University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-17
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698197 on ClinicalTrials.gov